VEGFA and dry age related macular degeneration: Whereas wet AMD can be impeded (to a certain degree) by intravitreal treatment with the anti-vascular endothelial growth factor (anti-VEGF), the dry AMD component of the disease cannot be therapeutically influenced which indeed seems to be somewhat clinically distinct [1, 4, 6, 7].